Bilal Rabahoğlu

Dr. Bilal Rabahoğlu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 August 2025 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
BBBurcu Baran
Burcu Baran
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
BRBilal Rabahoğlu
Bilal Rabahoğlu
NTNuri Tutar
Nuri Tutar
IGİnCi Gülmez
İnCi Gülmez
Background: Pneumonia is a lung parenchyma infection with clinical presentations ranging from mild to life‐threatening. Its severity depends on factors such as the causative pathogen, the host's immune response, and existing comorbidities. This study aimed to investigate the prognostic value of novel inflammatory biomarkers for predicting in‐hospital mortality in patients with community‐acquired pneumonia (CAP).Methods: This retrospective cross‐sectional study included 207 hospitalized patients diagnosed with clinically and radiologically confirmed pneumonia. Laboratory data collected upon admission included complete blood count parameters, C‐reactive protein (CRP), creatinine, and albumin levels. Systemic inflammatory biomarkers such as the neutrophil‐to‐lymphocyte ratio (NLR), platelet‐to‐lymphocyte ratio (PLR), CRP‐to‐albumin ratio (CAR), CRP‐to‐lymphocyte ratio (CLR), systemic immune‐inflammation index (SII), systemic inflammatory response index (SIRI), prognostic nutritional index (PNI), and C‐reactive protein‐albumin‐lymphocyte (CALLY) index were calculated.Results: The cohort was predominantly male (69%, n = 142) with a mean age of 62.1 ± 16.3 years. The median hospital stay was 8 days, with an 11% mortality rate. Malignancy was more frequent in the nonsurvivor group (p = 0.001). Nonsurvivors had significantly lower hemoglobin (p < 0.001) and albumin (p = 0.004) levels, while CRP (p = 0.024) and creatinine (p = 0.002) were elevated. NLR (p = 0.009), CAR (p = 0.011), CLR (p = 0.006), SII (p = 0.013), and SIRI (p = 0.024) were higher in nonsurvivors, while PNI (p = 0.010) and CALLY (p = 0.003) were lower.Conclusion: Novel inflammatory biomarkers, particularly the CALLY index, are valuable for mortality prediction in CAP, aiding in risk stratification and early management.

5 June 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
BBBurcu Baran
Burcu Baran
BRBilal Rabahoğlu
Bilal Rabahoğlu
NTNuri Tutar
Nuri Tutar
IGİnci Gülmez
İnci Gülmez
Background and Objectives: Artificial intelligence (AI) chatbots are increasingly employed for the dissemination of health information; however, apprehensions regarding their accuracy and reliability remain. The intricacy of sarcoidosis may lead to misinformation and omissions that affect patient comprehension. This study assessed the usability of AI-generated information on sarcoidosis by evaluating the quality, reliability, readability, understandability, and actionability of chatbot responses to patient-centered queries. Methods: This cross-sectional evaluation included 11 AI chatbots comprising both general-purpose and retrieval-augmented tools. Four sarcoidosis-related queries derived from Google Trends were submitted to each chatbot under standardized conditions. Responses were independently evaluated by four blinded pulmonology experts using DISCERN, the Patient Education Materials Assessment Tool—Printable (PEMAT-P), and Flesch–Kincaid readability metrics. A Web Resource Rating (WRR) score was also calculated. Inter-rater reliability was assessed using intraclass correlation coefficients (ICCs). Results: Retrieval-augmented models such as ChatGPT-4o Deep Research, Perplexity Research, and Grok3 Deep Search outperformed general-purpose chatbots across the DISCERN, PEMAT-P, and WRR metrics. However, these high-performing models also produced text at significantly higher reading levels (Flesch–Kincaid Grade Level > 16), reducing accessibility. Actionability scores were consistently lower than understandability scores across all models. The ICCs exceeded 0.80 for all evaluation domains, indicating excellent inter-rater reliability. Conclusions: Although some AI chatbots can generate accurate and well-structured responses to sarcoidosis-related questions, their limited readability and low actionability present barriers for effective patient education. Optimization strategies, such as prompt refinement, health literacy adaptation, and domain-specific model development, are required to improve the utility of AI chatbots in complex disease communication.

1 January 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
SASibel Akın
Sibel Akın
DKDerya Kocaslan
Derya Kocaslan
BBBurcu Baran
Burcu Baran
BRBilal Rabahoğlu
Bilal Rabahoğlu
IGİnCi Gulmez
İnCi Gulmez
Background/Aim: Chronic obstructive pulmonary disease (COPD) is often complicated by sarcopenia, a condition of reduced muscle mass and function that adversely affects quality of life, lung function, and exacerbation rates. Ultrasonography could be an effective tool for detecting sarcopenia, notably by assessing diaphragmatic function, which may indicate muscle health in COPD patients. This study aims to evaluate the effectiveness of diaphragmatic ultrasound in detecting sarcopenia among COPD patients. Materials and Methods: Thirty-five patients with COPD, with a forced expiratory volume in one second (FEV1) between 30% and 80%, were consecutively enrolled in this cross-sectional and double-blind study. Sarcopenia was defined using the European Working Group on Sarcopenia in Older People 2 (EWGSOP2) criteria. Muscle mass was assessed with bioelectrical impedance analysis (BIA), muscle strength was assessed using the handgrip test and physical performance was assessed using a 4-meter gait speed test. Pulmonary function tests (PFT) (including maximum inspiratory pressure-MIP and maximum expiratory pressure-MEP) were performed. Diaphragm excursion and thickness at residual volume, functional residual capacity, and total lung capacity were measured using ultrasound. The diaphragm thickening fraction was calculated during normal (TF) and deep breathing (TLC-TF). Results: Seventeen of 35 patients (48.6%) were found to be sarcopenic. Diaphragm thickness did not show significant variation between the groups. Both TF (27.43%) and TLC-TF (39.7%) were found to be lower in the sarcopenic group (p< 0.05). The diaphragmatic excursion in the sarcopenic group was found to be 1.38 cm (p=0.078). There was no difference in median MIP and MEP values between the groups. Conclusion: Diaphragmatic TF may be a valuable tool for detecting sarcopenia in COPD patients, which may vary independently of PFTs. This study highlights TF as a potential auxiliary measure, but further research with larger sample sizes and additional parameters is needed to confirm its clinical utility.

29 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BBBurcu Baran
Burcu Baran
FŞFiliz Miraç Şimşek
Filiz Miraç Şimşek
HDHasan Durmus
Hasan Durmus
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
BRBilal Rabahoğlu
Bilal Rabahoğlu
FOFatma Sema Oymak
Fatma Sema Oymak
Background/Objectives: Obesity is a significant risk factor for obstructive sleep apnea (OSA); however, conventional anthropometric measures, such as body mass index (BMI), may not fully reflect the physiological burden associated with adiposity. The triponderal mass index (TMI) has been proposed as an alternative anthropometric indicator, while inflammation-related biomarkers have emerged as potential complementary tools for characterizing OSA severity. This study aimed to evaluate the relationships between BMI, TMI, hypoxemia, and systemic inflammation, and to assess whether combining anthropometric indices with inflammatory biomarkers improves the identification of severe OSA. Methods: In this retrospective cross-sectional study, 238 adults undergoing full-night polysomnography were classified into four groups: non-OSA, mild OSA, moderate OSA, and severe OSA, based on the apnea–hypopnea index (AHI). Anthropometric indices, polysomnographic parameters, and a comprehensive panel of laboratory biomarkers—including C-reactive protein (CRP), neutrophil- and platelet-derived inflammatory indices, prognostic nutritional index (PNI), CRP-to-albumin ratio (CAR), and CRP-to-lymphocyte ratio (CLR)—were analyzed. Associations were evaluated using Spearman correlation analyses, and diagnostic performance for severe OSA (AHI ≥ 30 events/h) was assessed using receiver operating characteristic (ROC) analyses, DeLong tests, and multivariable models. Results: Both BMI and TMI increased progressively with OSA severity (both p < 0.001) and showed comparable correlations with AHI and nocturnal oxygenation parameters. ROC analyses demonstrated similar discriminative performance for severe OSA (BMI AUC = 0.834; TMI AUC = 0.823; p = 0.229). Among inflammatory biomarkers, CRP, multi-inflammatory index (MII), CAR, and CLR showed moderate diagnostic accuracy. Among the evaluated markers, serum albumin (AUC = 0.836) and PNI demonstrated the highest diagnostic accuracy (AUC = 0.994). A combined model integrating BMI or TMI with PNI achieved near-perfect discrimination for severe OSA (BMI-based AUC = 0.9956; TMI-based AUC = 0.9969), while the addition of CRP-based inflammatory markers did not yield meaningful incremental benefit. Conclusions: BMI and TMI exhibit comparable performance in relation to OSA severity, hypoxemia, and systemic inflammation, with no clear superiority of TMI over BMI in adult patients. Inflammation-related biomarkers—particularly PNI—provide additional discriminatory value beyond anthropometric measures alone. Integrating simple biochemical markers with anthropometric and polysomnographic parameters may enhance risk stratification and identification of severe OSA phenotypes.

13 December 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BRBilal Rabahoğlu
Bilal Rabahoğlu
FOFatma Sema Oymak
Fatma Sema Oymak
BBBurcu Baran
Burcu Baran
NTNuri Tutar
Nuri Tutar
IGİnCi Gülmez
İnCi Gülmez
IYİnSu Yilmaz
İnSu Yilmaz
There is limited information about peripheral blood eosinophilia (PBE) and airway obstruction in sarcoidosis. Since pulmonary sarcoidosis affects the airways, it is often confused with asthma. The aims of the study are to investigate airway obstruction and PBE in sarcoidosis patients and to examine the similarity of clinical presentation with asthma. The patients matching the ATS/ERS/WASOG diagnosis criteria and were between 18 and 80 years of age were included consecutively between 2018 and 2020. Other diseases causing granulomas were excluded. A total of 84 patients were included of which 26 (31%) had a PBE level of ≥300 μL with no significant difference seen between sarcoidosis stage and PBE (p > 0.05). A significant (p < 0.05) decrease was only seen in FEV1 as the stage of sarcoidosis progressed. Respectively 31 (36.9%), 12 (14.3%) and 4 (4.8%) patients had an obstructive, restrictive and mixed respiratory function disorder. Twenty-four (28.6%) subjects with sarcoidosis had history of asthma. Spring fever, eczema, and skin/nose allergy were noticed in 17 (20.2%) of the patients. Mild PBE may be seen in sarcoidosis. Patients applying with PBE, airway obstruction, bronchial hyperreactivity along with spring fever, eczema, skin/nose allergy, wheezing, chest tightness, shortness of breath and cough may be also evaluated in terms of sarcoidosis.

23 December 2025 in Tuberk Toraks
Verified
Journal Article
Closed access
NYNur Aleyna Yetkin
Nur Aleyna Yetkin
FEFatma Yi̇ğİt Erarslan
Fatma Yi̇ğİt Erarslan
BBBurcu Baran
Burcu Baran
BRBilal Rabahoğlu
Bilal Rabahoğlu
NTNuri Tutar
Nuri Tutar
IGİnCi Gülmez
İnCi Gülmez
Pulse oximeter is commonly used by chronic obstructive pulmonary disease (COPD) patients for long-term oxygen therapy (LTOT) to monitor oxygen levels. This study investigated the association between oximeter use, anxiety severity, symptom burden, and healthcare utilization in this population. This prospective observational study included 110 individuals with COPD who underwent LTOT. Data were collected on pulmonary function, modified Medical Research Council (mMRC) scores, and daily pulse oximeter use. Anxiety severity was assessed using the Beck Anxiety Inventory (BAI). Healthcare utilization in the previous year, including outpatient-treated and inpatient-treated exacerbations, intensive care unit admissions, and non-exacerbation-related hospital admissions, was analyzed. Linear regression analysis was performed to identify the independent predictors of nonexacerbation-related hospital admissions. Among the participants, 68 (61.8%) reported using a home pulse oximeter. There were no significant differences in BAI scores (p= 0.678), oxygen therapy duration (p= 0.530), or mMRC scores (p= 0.251) between the groups. However, non-users had significantly higher rates of non-exacerbation-related hospital admissions than users (p< 0.001). In multivariable analysis, not using pulse oximeter independently predicted more non-exacerbationrelated admissions (B= 1.63, 95% CI: 0.94-2.32, p< 0.001), whereas anxiety and physiological measures were not significant. Pulse oximeter use was not associated with anxiety or symptom severity among the patients with COPD receiving LTOT. However, non-use of pulse oximeter was independently associated with increased non-exacerbation-related hospital admissions. These findings suggest that pulse oximeter may support patient self-management and reduce unnecessary healthcare utilization, without contributing to anxiety.